Massive growth opportunity for robot-assisted surgery worldwide has been a positive for Californian-based Intuitive Surgical. Around 7,000 of the company’s Da Vinci robot platform are already operational in hospitals globally (including New Zealand), and its share price has risen more than 32% over the past six months. On AM, Milford Investment Analyst Dr Deborah Lambie explains the transformative effect of robotic-assisted surgery for surgeons and patients, and why the United States is leading the way.